Overview

Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome

Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
Study to test the effect of the drug "L-ornithine.L-aspertate" (LOLA) on microorganisms in the digestive tract in patients with liver cirrhosis (damage of the liver due to liver disease)
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Graz
Collaborator:
CBmed Ges.m.b.H.
Treatments:
N-Methylaspartate